- October 6, 2021
CarthroniX receives strong proof-of-concept data indicating high efficacy of a novel drug candidate in the bleomycin-induced model of pulmonary fibrosis.
CarthroniX receives strong proof-of-concept data indicating high efficacy of a novel anti-fibrotic drug candidate.